Morphine Equivalent Dose (MED) remains a valuable indicator of risk when it comes to opioids, and we continue to see downward trends through 2018 that align with best practice recommendations. In particular, declines in long-term high MED opioid claims and an increase in the presence of opioid overdose reversal agents when MED is over 50 represent two areas that impact patient safety. Recognizing such indicators of risk can aid in identifying opportunities for intervention particularly through outreach with medical providers and/or injured workers, medication review, ongoing monitoring, and recommendations for guideline-supported risk-reducing measures. Watch the video blog to learn more.